Stay updated on Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.

Latest updates to the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference1%
- Check26 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check47 days agoChange DetectedThe study has been terminated due to insufficient patient recruitment, with only 15 participants enrolled instead of the target of 19. Additionally, the plan to share individual participant data has been clarified, indicating no plan for sharing due to the early termination.SummaryDifference14%
Stay in the know with updates to Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.